Open-Label Study of the Safety and Tolerability of STX209 in Subjects With Autism Spectrum Disorders
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bryan King, MD, PhD
Seattle Children's Hospital
Principal Investigator - Craig Erikson, MD
Riley Hospital for Children
Principal Investigator - James McCracken, MD
University of California, Los Angeles
Principal Investigator - Jeremy Veenstra-VanderWeele, MD
Vanderbilt Kennedy Center
Principal Investigator - Lawrence Ginsberg, MD
Red Oaks Psychiatry Associates, PA
Principal Investigator - Lawrence Scahill, PhD
Yale University
Principal Investigator - Linmarie Sikich, MD
University of North Carolina Neurosciences Hospital
Principal Investigator - Raun Melmed, MD
Southwest Autism Research & Resource Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southwest Autism Research & Resource Center
Phoenix, Arizona, United States
- University of California-Los Angeles Neuropsychiatric Institute
Los Angeles, California, United States
- Yale Child Study Center
New Haven, Connecticut, United States
- Riley Hospital for Children
Indianapolis, Indiana, United States
- University of North Carolina Neurosciences Hospital
Chapel Hill, North Carolina, United States
- Vanderbilt Kennedy Center
Nashville, Tennessee, United States
- Red Oaks Psychiatry Associates, Pa
Houston, Texas, United States
- Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Feb 2009
- Primary completion
- 30 Jun 2010
- Completion
- 30 Sept 2010
- Last update posted
- 14 Jun 2013
- Registered enrollment
- 32
- Registry id
- NCT00846547
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.